150
Views
43
CrossRef citations to date
0
Altmetric
Research Article

Immunodiagnosis of pemphigus and mucous membrane pemphigoid

, , , , &
Pages 226-234 | Published online: 02 Jul 2009

References

  • Nguyen QD, Foster CS. Cicatricial pemphigoid: diagnosis and treatment. Int Ophthalmol Clin 1996;6:41–60.
  • Ahmed AR, Hombal SM. Cicatricial pemphigoid. Int J Dermatol 1986;25:90–6.
  • Setterfield J, Shirlaw PJ, Kerr-Muir M, Bhogal BS, Morgan PR, Tilling K, et al. Mucous membrane pemphigoid: A dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease. Br J Dermatol 1998;138:602–10.
  • Ahmed AR, Graham J, Jordon RE, Provost TT. Pemphigus: current concepts. Arm Intern Med 1980;92:396–405.
  • Ramirez-Amador VA, Esquivel-Pedraza L, Orozco-Topete R. Frequency of oral conditions in a dermatology clinic. Int J Dermatol 2000;39:501–5.
  • Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999;112:411–8.
  • Buxton RS, Cowin P, Franke WW, Yarrod DR, Green KJ, King IA, et al. Nomenclature of the desmosomal cadherins. J Cell Biol 1993;121:481–3.
  • Shirakata Y, Amagai M, Hanakawa Y, Nishikawa T, Hashimoto K. Lack of mucosal involvement in pemphigus foliaceus may be due to low expression of desmoglein 1. J Invest Dermatol 1998; 110:76–8.
  • Champliaud MF, Lunstrum GP, Rousselle P, Nishiyama T, Keene DR, Burgeson RE. Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 1996;132:1189–98.
  • Hopkinson SB. Baker SE. Jones JC. Molecular genetic studies of a human epidermal autoantigen (the 180-kD bullous pemphigoid antigen/BP180 ) identification of functionally important sequences within the BP180 molecule and evidence for an interaction between BP180 and alpha 6 integrin. J Cell Biol 1995;130:117–25.
  • Cozzani E, Cacciapuoti M, Parodi A, Ghohestani R, Rebora A. Desmosomes and their autoimmune pathologies. Eur J Dermatol 2000;10:255–61.
  • Jolliffe DS, Sim-Davis D. Cicatricial pemphigoid in a young girl. Chin Exp Dermatol 1977;2:281–4.
  • Laskaris G, Sklavounou A, Stratigos J. Bullous pemphigoid, dcatridal pemphigoid and pemphigus vulgaris: a comparative clinical survey of 278 cases. Oral Surg Oral Med Oral Pathol 1982;54: 656–62.
  • Mondino BJ, Linstone FA. Ocular pemphigoid. Chin Dermatol 1987;5:28–35.
  • Foster CS. Cicatricial pemphigoid. Trans Am Ophthalmol 1986; 84:527–663.
  • Lever WF. Commentary on Brunsting LA, Perry HO. Benign pemphigoid? A report of seven cases with chronic, scarring, herpetiform plaques about the head and neck. Arch Dermatol 1957;75:489–501.
  • Hanson RD, Olsen KD, Rogers RS. Upper aerodigestive tract manifestations of cicatridal pemphigoid. Arm Otol Rhinol Laryngol 1988;97:493–9.
  • Hardy KM, Perry HO, Pingree GC, Kirby TJ. Benign mucous membrane pemphigoid. Arch Dermatol 1971;104:467–75.
  • Zaltas MM, Ahmed R, Foster CS. Association of HLA-DR4 with ocular dcatricial pemphigoid. Curr Eye Res 1989;8: 189–93.
  • Ahmed AR, Foster S, Zaltas M, Notani G, Awdeh Z, Alper CA, et al. Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sd USA 1991;88:11579–82.
  • Nayar M, Wojnarowska F, Venning V, Taylor CJ. Association of dcatridal pemphigoid and autoimmunity: is there an immuno-genetic basis? J Am Acad Dermatol 1991;25:1011–5.
  • Venning VA, Frith PA, Bron AJ, Millard PR, Wojnarowska F. Mucosal involvement in bullous and cicatridal pemphigoid: a clinical and immunopathological study. Br J Dermatol 1988; 118:7–15.
  • Setterfield J, Theron J, Welsh K, Vaughan R, Shirlaw P, Wojnarowska F, et al. Mucous membrane pemphigoid: HLA DQB1*030 1 allele is associated with all clinical sites of involvement and may be linked to anti-basement membrane IgG production. Br J Dermatol 2001;145:406–14.
  • Chan LS, Hammerberg C, Cooper KD. Significantly increased occurrence of HLA-DQB1*030 1 allele in patients with ocular dcatridal pemphigoid. J Invest Dermatol 1997;108: 129–32.
  • Mondino BJ, Ross AN, Rabin BS, Brown SI. Autoimmune phenomena in ocular cicatridal pemphigoid. Am J Ophthalmol 1983;101:1611–3.
  • Setterfield J, Shirlaw PJ, Bhogal BS, Tilling K, Challacombe SJ, Black MM. Cicatricial pemphigoid: serial titres of circulating IgG and IgA antibasement membrane antibodies correlate with disease activity. Br J Dermatol 1999;140:645–50.
  • Bernard P, Prost C, Aucouturier P, Durepaire N, Denis F, Bonnetblank JM. The subclass distribution of IgG autoantibodies in dcatridal pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol 1991;97:259–63.
  • Labib RS, Anhalt GJ, Patel HP, Mutasim DF, Diaz LA. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol 1986;136:1231–5.
  • Chan LS, Hammerberg C, Cooper KD. Cicatricial pemphigoid: identification of two distinct sets of epidermal antigens by IgA and IgG class circulating antibodies. Arch Dermatol 1990;126: 1466–8.
  • Domloge-Hultsch N, Gammon WR, Briggaman RA, Gil SG, Carter WG, Yancey KB. Epiligrin, the major human keratino-cyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. J Clin Invest 1992;90:1628–33.
  • Chan LS, Fine JD, Briggaman RA, Woodley DT, Hammerberg C, Drugge RJ, et al. Identification and partial characterization of a novel 105-kDalton lower lamina lucida autoantigen associated with a novel immune-mediated subepidermal blistering disease. J Invest Dermatol 1993;101:262–7.
  • Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Abendam D, et al. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 1996;106:141–6.
  • Bedane C, McMillan JR, Balding SD, Bernard P, Prost C, Bonnetblanc JM, et al. Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol 1997;108:901–7.
  • Murakami H, Nishioka S, Setterfield J, Bhogal BS, Black MM, Zillikens D, et al. Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphi-goid. J Dermatol Sci 1998;17:39–44.
  • Lish KM, Washenik K, Yancey KB, Yee C, Rico MJ. Anti-epiligrin cicatricial pemphigoid in a patient with HIV. J Am Acad Dermatol 1997;36:486–8.
  • Lenz P, Hsu R, Yee C, Yancey K, Volc-Platzer B, Stengl G, et al. Vernarbendesa Pemphigoid mit Autoantikorpern gegen Laminin-5 (Epiligrin) bei einer Patientin mit metastasierendem Endometriumkarzinom. Hautarzt 1998;49: 31–5.
  • Fujimoto W, Ishida-Yamamoto A, Hsu R, Nagao Y, Iizuka H, Yancey KB. Anti-epiligrin cicatricial pemphigoid: a case associated with gastric carcinoma and features resembling epidermolysis bullosa acquisita. Br J Dermatol 1998;139:682–7.
  • Setterfield J, Shirlaw PJ, Lazarova Z, Bryant BM, Bhogal BS, Harman K, et al. Paraneoplastic cicatricial pemphigoid. Br J Dermatol 1999;141:127–31.
  • Bhol K, Mohimen A, Neumann R, Yunis J, Foster CS, Yunis EJ, et al. Differences in the anti-basement membrance zone antibodies in ocular and pseudo-ocular cicatricial pemphigoid. Curr Eye Res 1996;15:521–32.
  • Domloge-Hultsch N, Anhalt GJ, Gammon WR, Lazarova Z, Briggaman R, Welch M, et al. Antiepiligrin cicatricial pemphi-goid. A subepithelial bullous disorder. Arch Dermatol 1994;130: 1521–9.
  • Smith EP, Taylor TB, Meyer LJ, Zone JJ. Identification of a basement membrane zone antigen reactive with circulating IgA antibody in ocular cicatricial pemphigoid. J Invest Dermatol 1993;101:619–23.
  • Nishikawa T, Hashimoto T, Shimizu H, Ebihara T, Amagai M. Pemphigus from immunofluorescence to molecular biology. J Dermatol Sci 1996;12:1–9.
  • Amagai M. Towards a better understanding of pemphigus autoimmunity. Br J Dermatol 2000;143:237–8.
  • Harman KE, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM The use of two substrates to improve the sensitivity of indirect immunofluorescence in the diagnosis of pemphigus. Br J Dermatol 2000;142:1135–9.
  • Harman KE, Gratian MJ, Bhogal BS, Challacombe SJ, Black MM. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol 2000;143: 343–8.
  • Miyagawa S, Amagai M, Iida T, Yamamoto Y, Nishikawa T, Shirai T. Late development of antidesmoglein 1 antibodies in pemphigus vulgaris: correlation with disease progression. Br J Dermatol. 1999; 141:1084–7.
  • Harman KE, Seed PT, Gratian MJ, Bhogal BS, Challacombe SJ, Black M1'vI. The severity of cutaneous and oral pemphigus is related to desmoglein 1 and 3 antibody levels. Br J Dermatol 2001;144: 775–80.
  • Harman KE, Gratian MJ, Seed PT, Bhogal BS, Challacombe SJ, Black MM. Diagnosis of pemphigus by ELISA: a critical evaluation of two ELISAs for the detection of antibodies to the major pemphigus antigens, desmoglein 1 and 3. Chin Exp Dermatol 2000;25:236–40.
  • Weinberg MA, Insler MS, Campen RB. Mucocutaneous features of autoimmune blistering diseases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:517–34.
  • Scully, C, Almeida OPD, Porter SR, Gilkes J. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol 1999;140: 84–9.
  • Virgili A, Thrombelli L, Calura G. Sudden vegetation of the mouth: pemphigus vegetans of the mouth (Hallopeau type). Arch Dermatol 1992;128:398-9, 401–2.
  • Allen CM, Camisa C. Paraneoplastic pemphigus: a review of the literature. Oral Dis. 2000;6:208–14.
  • Wong KC, Ho KK. Pemphigus with pemphigoid-like presenta-tion, associated with squamous cell carcinoma of the tongue. Australas J Dermatol 2000;41:178–80.
  • Laskaris G, Papavasiliou S, Bovopoulou 0, Nicolis G. Associa-tion of oral pemphigus with chronic lymphocytic leukaemia Oral Surg Oral Med Oral Pathol 1980;2:244–9.
  • Perniciaro C, Kuechle MK, Colon-Otero G, Solberg LA, Cockerill KJ, Hook CC, et al. Paraneoplastic pemphigus: a case of prolonged survival. Mayo Clin Proc 1994;69:851–5.
  • Bialy-Golan A, Brenner S, Anhalt GJ. Paraneoplastic pemphi-gus: oral involvement as the sole manifestation. Acta Derm Venereol (Stockh) 1996;76:253–4.
  • Kricheli D, David M, Frusic-Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 2000;143: 337–42.
  • Loiseau P, Lecleach L, Prost C, Lepage V, Busson M, Bastuji-Garin S, et al. HLA class II polymorphism contributes to specify desmoglein derived peptides in pemphigus vulgaris and pemphi-gus foliaceus. J Autoimmun 2000;15:67–73.
  • Degaldo JC, Yunis DE, Bozon MV, Salazar M, Deulofeut R, Turbay D, et al. MHC class II alleles and haplotypes in patients with pemphigus vulgaris from India. Tissue Antigens 1996;48: 668–72.
  • Emery DJ, Diaz LA, Fairley JA, Lopez A, Taylor AT, Giudice GJ. Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol 1995;104:323–8
  • Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. hit Arch Allergy Immunol 2000;122:91–100.
  • Seishima M, Iwasaki-Bessho Y, Itoh Y, Nozawa Y, Amagai M, Kitajima Y. Phosphatidylcholine-specific phospholipase C, but not phospholipase D, is involved in pemphigus IgG-induced signal transduction. Arch Dermatol Res 1999;291:606–13.
  • Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Chin Invest 2000;106: 1467–79.
  • Hertl M, Riechers R. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris. J Dermatol 1999;26:748–52.
  • Toto P, Felidani C, Amerio P, Suzuki H, Wang B, Shivji GM, et al. Immune modulation in pemphigus vulgaris: role of CD28 and IL-10. J Immunol 2000;164:522–9.
  • Sdubba JJ. Autoimmune aspects of pemphigus vulgaris and mucosal pemphigoid. Adv Dent Res 1996;10:52–6.
  • Zegarelli D, Zegarelli E. Intraoral pemphigus vulgaris. Oral Surg 1977;44:384–93.
  • Orlowski WA, Bressman E, Doyle JL, Chassens Al. Chronic pemphigus vulgaris of the gingiva. J Periodontol 1983;54:685–9.
  • Dobrev H, Popova L, Vlashev D. Proteinase inhibitors and pemphigus vulgaris. An in vitro and in vivo study. Arch Dermatol Res 1996;288:648 —55.
  • Proby CM, Ota T, Suzuki H, Koyasu S, Gamou S, Shimizu N, et al. Development of chimeric molecules for recognition and targeting of antigen-specific B cells in pemphigus vulgaris. Br J Dermatol 2000;142:321 —30.
  • Grando SA. Autoimmunity to keratinocyte acetylcholine recep-tors in pemphigus. Dermatology 2000;201:290–5.
  • Sarrett Y, Ream A, Nicolas JF, Su H, Thivolet J. Bullous pemphigoid and cicatridal pemphigoid: immunoblotting detec-tion of involved autoantigens. Autoimmunity 1989;2:145–53.
  • Ghohestani RF, Nicolas JF, Rousselle P, Claudy AL. Identifica-tion of a 168-kDa mucosal antigen in a subset of patients with cicatridal pemphigoid. J Invest Dermatol 1996;107:136 —9.
  • Haftek M, Zone JJ, Taylor TB, Kowalewski C, Chorzelski TP, Schmitt D. Immunogold localization of the 97-kD antigen of linear IgA bullous dermatosis (LABD) detected with patients' sera. J Invest Dermatol 1994;103:656–9.
  • Anhalt GJ, Kim SC, Stanley JR, Korman NJ, Jabs DA, Kory M, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990;323:1729 — 35.
  • Ishii K, Amagai M, Ohata Y, Shimizu H, Hashimoto T, Ohya K, et al. Development of pemphigus vulgaris in a patient with pemphigus foliaceus: antidesmoglein antibody profile shift confirmed by enzyme-linked immunosorbent assay. J Am Acad Dermatol 2000;42:859 —61.
  • Korman N, Eyre R, Zone J, Stanley J. Induced pemphigus: autoantibodies directed against the pemphigus antigen com-plexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 1991;96:273–6.
  • Yasuda H, Kobayashi H, Hashimoto T, Itoh K, Yamane M, Nakamura J. Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review. Br J Dermatol 2000;143:144–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.